CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 8 No. 11
 

Candlelight Vigil Rekindles Enthusiasm of ‘The March’

November 1, 1999

WASHINGTON—Cancer survivors, their families, and friends gathered in front of the Lincoln Memorial for “Rays of Hope,” a candlelight vigil to mark the first anniversary of The March. That event brought tens of thousands to Washington last September to a rally aimed at making cancer the nation’s leading research priority.

Although this year’s crowd was smaller—5,000 or so—the enthusiasm and rhetoric were just as strong, as speaker after speaker emphasized the need for citizen involvement in increasing funds for cancer research and access to quality cancer care.

ABC television personality Sam Donaldson, the evening’s emcee, hit the theme immediately. “You cannot tell me that the mind that invented ways to keep from being eaten by the saber tooth tiger and discovered the wheel cannot now invent the way to cure cancer,” he said. “But it takes determination, and it takes money.”

Sidney Kimmel, founder of the Jones Apparel Group and the Sidney Kimmel Foundation for Cancer Research, urged the 60 million Americans “touched by cancer” to make increased research funding an issue in the upcoming presidential election.

“Gore, Bradley, and Bush, and the other presidential candidates, are touring our country, supposedly listening to Americans and defining their campaign positions,” he said. “Make them listen to our needs for cancer research funding. When they come to your city, ask them the question: Will they support $10 billion in annual funding for cancer research now?”

National Cancer Institute director

Richard D. Klausner, MD, evoked a new era of cancer research and what added funding could bring. “As we enter a new millennium, we can truly say that change is imminent,” he said. “The revolution in molecular biology and genetics, along with the emergence of powerful new technologies, are allowing us—for the first time in human history—to see the centers of cells that go awry in cancer, to explain how tumor cells behave, and to understand how this abnormal cell can prosper.”

But clearly the crowd favorite was Queen Noor of Jordan (see photograph), whose husband, King Hussein, died of lymphoma. “You can promote awareness and cooperation, political action and scientific progress that can have an impact on health care, not only here in the United States for Americans, but for people around the world,” she said.

Prior to the vigil, people had an opportunity to visit an exhibit area, which included sections from the Children’s Cancer Quilt. With many sections on display in communities across the country, there were fewer sections than were displayed at The March, but they were no less moving. Each handmade panel honored a youngster felled by cancer: “Remember the Laughter. Molly Elizabeth Koss, 9/19/92-3/2/98”; “Laurie Blahnik, 10/20/70-12/28/79. Lymphoma”; “Ricky Blahnik, 8/18/69-2/22/77. Brain tumor.”

At the education tent, nearly a score of organizations—including the Lymphoma Research Foundation, Leukemia Society, National Breast Cancer Coalition, and Colon Cancer Alliance, offered information and assistance.

The Coalition of National Cancer Cooperative Groups (CNCCG) debuted its virtual cancer quilt at the vigil. Cancer survivors can have their photograph and their story placed on a website, www.cancerquilt.com. The coalition calls the endeavor “a celebration of and a tribute to the many courageous people who have faced cancer.”

The vigil was sponsored by the National Coalition for Cancer Survivorship (NCCS), with financial support from the Sidney Kimmel Foundation and two dozen other organizations and corporations. These groups include Bristol-Myers Squibb Oncology, Bell Atlantic Mobile, General Motors Corporation, and Genentech BioOncology.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy